Lung function trajectories in a cohort of patients with moderate-to-severe asthma on biologics

Ayobami Akenroye from Harvard Medical School, USA, presents their research article published in Allergy:
Nopsopon T, Barrett NA, Phipatanakul W, Laidlaw TM, Weiss ST, Akenroye A. Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy. 2024; doi.org/10.111...
Follow Allergy on:
Facebook: / eaaciallergy
Twitter: / allergyeaaci
LinkedIn: / allergy-eaaci
Instagram: / allergy.eaaci
Like, share and comment on our videos, thank you.
journalallergy...